White label – Pompe disease - ClinicalTrials.eu

A study to evaluate the safety and how the body uses ublituximab injections in patients with multiple sclerosis

Recruiting

2 1 1 1
Investigated Drugs:
- Ublituximab
A study to evaluate the safety and effectiveness of filgotinib in children and adolescents aged 8 to 17 years with polyarticular juvenile idiopathic arthritis

Recruiting

3 1 1 1
Investigated Drugs:
- Filgotinib
+4
A study to evaluate the safety and effectiveness of surlorian in adults with RYR1-related myopathy

Recruiting

2 1
Investigated Diseases:
- Congenital myopathy
A study to evaluate the safety and effectiveness of ANXV in patients with diabetic retinopathy or retinal vein occlusion

Recruiting

2 1 1
Investigated Diseases:
- Diabetic retinopathy
- Retinal vein occlusion
Investigated Drugs:
- ANXV
A study to evaluate the safety and effectiveness of filgotinib in children and adolescents with juvenile idiopathic arthritis.

Recruiting

3 1 1 1
Investigated Diseases:
- Juvenile idiopathic arthritis
Investigated Drugs:
- Filgotinib
Study of pembrolizumab, capecitabine, or olaparib in patients with early-stage triple negative breast cancer and remaining disease after initial treatment

Recruiting

3 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
A study to evaluate the effectiveness and safety of zasocitinib in children and adolescents with moderate-to-severe plaque psoriasis

Recruiting

3 1
Investigated Diseases:
- Psoriasis
Investigated Drugs:
- Zasocitinib
A study to evaluate the effectiveness and safety of LAD328 in adults with moderate to severe hidradenitis suppurativa

Recruiting

2 1 1
Investigated Diseases:
- Hidradenitis
Investigated Drugs:
- Sodium Chloride
A study to evaluate the effectiveness and safety of BFB759 in adults with moderate to severe hidradenitis suppurativa

Recruiting

2 1
A study to evaluate the safety of VTx-002 in patients with amyotrophic lateral sclerosis.

Recruiting

2 1 1
Investigated Diseases:
- Amyotrophic lateral sclerosis
Investigated Drugs:
- Sodium Dihydrogen Phosphate Dihydrate
- VTX-002

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies